Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2175 of 3546 entries
View as:

Efficacy and Safety In Poorly Controlled Type 2 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00044460 Org: User:
Start: 05/31/02 End: 04/10/03 Due: 04/10/04

Multiple Treatment Session Study to Assess GSK2398852 Administered Following and Along With GSK2315698

Phase: N/A Priority: Normal
NCT ID: NCT03044353 Org: User:
Start: 07/10/17 End: 01/03/19 Due: 01/03/20

SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT00110799 Org: User:
Start: 04/30/05 End: 11/30/06 Due: 11/30/07

Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes

Phase: N/A Priority: Normal
NCT ID: NCT00351923 Org: User:
Start: 03/31/06 End: 12/31/06 Due: 12/31/07

Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness

Phase: N/A Priority: Normal
NCT ID: NCT03543176 Org: User:
Start: 05/31/18 End: 08/21/19 Due: 08/21/20

Phase I Study of GW856553 (Losmapimod)

Phase: N/A Priority: Normal
NCT ID: NCT01648192 Org: User:
Start: 07/24/12 End: 10/26/12 Due: 10/26/13

To Investigate the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleanser in Healthy Females With Sensitive Skin

Phase: N/A Priority: Normal
NCT ID: NCT03172364 Org: User:
Start: 06/12/17 End: 07/13/17 Due: 07/13/18

Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance

Phase: N/A Priority: Normal
NCT ID: NCT01039805 Org: User:
Start: 12/31/09 End: 07/31/11 Due: 07/31/12

A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622

Phase: N/A Priority: Normal
NCT ID: NCT03306043 Org: User:
Start: 11/13/17 End: 12/30/19 Due: 12/30/20

Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab

Phase: N/A Priority: Normal
NCT ID: NCT00240578 Org: User:
Start: 11/30/03 End: 06/30/13 Due: 06/30/14

Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)

Phase: N/A Priority: Normal
NCT ID: NCT00329745 Org: User:
Start: 01/31/07 End: 07/31/08 Due: 07/31/09

To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population

Phase: N/A Priority: Normal
NCT ID: NCT02937636 Org: User:
Start: 09/19/17 End: 12/22/17 Due: 12/22/18

Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00280423 Org: User:
Start: 01/31/06 End: 02/28/07 Due: 02/28/08

Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic Region

Phase: N/A Priority: Normal
NCT ID: NCT00197028 Org: User:
Start: 08/23/05 End: 12/27/07 Due: 12/27/08

Long Term Safety Of GW685698X Via Nasal Biopsy

Phase: N/A Priority: Normal
NCT ID: NCT00224523 Org: User:
Start: 09/30/05 End: 02/28/07 Due: 02/28/08

Bupropion & Cardio Birth Defect (Slone)

Phase: N/A Priority: Normal
NCT ID: NCT01597661 Org: User:
Start: 09/30/11 End: 08/31/12 Due: 08/31/13

Study In People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00196989 Org: User:
Start: 09/30/05 End: 04/30/07 Due: 04/30/08

A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00317174 Org: User:
Start: 07/31/03 End: 04/30/04 Due: 04/30/05

A Bioequivalence Study of Three, 2 mg Nicotine Chewing Gums (Two Tests and One Reference) in Healthy Adult Smokers

Phase: N/A Priority: Normal
NCT ID: NCT02688374 Org: User:
Start: 03/11/16 End: 06/12/16 Due: 06/12/17

Persistence and Booster Study of GSK Biologicals' Meningococcal Vaccine (GSK134612) in Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT01266993 Org: User:
Start: 01/03/11 End: 05/17/14 Due: 05/17/15

Extended Access of Momelotinib in Adults With Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT03441113 Org: User:
Start: 05/03/18 End: 12/31/26 Due: 12/31/27

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

Phase: N/A Priority: Normal
NCT ID: NCT00519636 Org: User:
Start: 08/31/07 End: 11/30/07 Due: 11/30/08

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05960097 Org: User:
Start: 08/01/23 End: 08/30/24 Due: 08/30/25

Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04475939 Org: User:
Start: 10/26/20 End: 09/24/25 Due: 09/24/26

Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01205217 Org: User:
Start: 12/31/10 End: 12/31/10 Due: 12/31/11